Chemical nanotherapy: Nitroxyl radical-containing nanoparticle protects neuroblastoma SH-SY5Y cells from Aβ-induced oxidative stress

Therapeutic Delivery

Volumn 2, Issue 5, 2011, Pages 585-597

  Chonpathompikunlert, Pennapa ^a   Yoshitomi, Toru ^a   Han, Junkyu ^a   Toh, Kazuko ^a   Isoda, Hiroko ^a   Nagasaki, Yukio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; DNA; HYDROXYL RADICAL; NANOPARTICLE; NITROXYL RADICAL CONTAINING NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN SH SY5Y; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DNA OXIDATION; HUMAN; LIPID PEROXIDATION; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN OXIDATION;

EID: 79956158016     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.11.27     Document Type: Article

References (57)

1. Wang R, Zhou J, Tang XC. Tacrine attenuates hydrogen peroxide-induced apoptosis by regulating expression of apoptosisrelated genes in rat PC12 cells. Brain Res. Mol. Brain Res. 107(1), 1-8 (2002). (Pubitemid 35333199)
2. Markesbery WR. The role of oxidative stress in Alzheimer's disease. Free Radic. Biol. Med. 23(1), 134-147 (1997). Key paper about amyloid β-peptide inducing oxidative stress, and its correlation with neurodegenerative diseases, including Alzheimer's disease. (Pubitemid 27217017)
3. Pratico D, Delanty N. Oxidative injury in diseases of the central nervous system: Focus on Alzheimer's disease. Am. J. Med. 109, 577-585 (2000). Key paper about amyloid β-peptide inducing oxidative stress, and its correlation with neurodegenerative diseases, including Alzheimer's disease.
4. Kayed R, Head E, Thompson JL et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003). (Pubitemid 36444329)
5. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444 (1995).
6. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10, 373-403 (1994). (Pubitemid 24372824)
7. Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: Potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32, 1050-1060 (2002). (Pubitemid 34603342)
8. Butterfield DA. Amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 36, 1307-1313 (2002). Key paper about amyloid β-peptide inducing oxidative stress, and its correlation with neurodegenerative diseases, including Alzheimer's disease. (Pubitemid 35469517)
9. Stegeman JJ, Hahn ME. Biochemistry and molecular biology of monooxygenase: Current perspectives on forms, functions, and regulation of cytochrome P450 in aquatic species? In:Aquatic Toxicology Malins DC, Ostrander GK (Eds.). Lewis Publishers, Boca Raton, FL, USA 87-206 (1994).
10. Hahn SM, Lepinski DL, DeLuca AM et al. Neurophysiological consequences of nitroxide antioxidants. Can. J. Physiol. Pharmacol. 73, 399-403 (1995).
11. Samuni A, Krishna CM, Riesz P et al. A novel metal-free low molecular weight superoxide dismutase mimic. J. Biol. Chem. 263, 17921-17924 (1998).
12. Mitchell JB, Samuni A, Krishna MC et al. Biologically active metal-independent superoxide dismutase mimics. Biochemistry 29, 2802-2807 (1990). (Pubitemid 20122615)
13. Krishna MC, Samuni A, Taira J et al. Stimulation by nitroxides of catalase-like activity of hemeproteins. Kinetics and mechanism. J. Biol. Chem. 271, 26018-26025 (1996). (Pubitemid 26347440)
14. Mitchell JB, DeGraff W, Kaufman D et al. Inhibition of oxygen-dependent radiation induced damage by the nitroxide superoxide dismutase mimic, TEMPOL. Arch. Biochem. Biophys. 289, 62-70 (1991).
15. Chonpathompikunlert P, Junkyu H, Kazuko T et al. TEMPOL protects human neuroblastoma SH-SY5Y cells against β-amyloid-induced cell toxicity. Eur. J. Pharmacol. 650, 544-549 (2011). This paper represents our first step to finding the effect of free 2,2,6,6 tetramethylpiperidinyl-N-oxyl (TEMPO) and free 4-hydroxy-TEMPO, until we can continue our work at this time.
16. Suy S, Mitchell JB, Samuni A et al. Nitroxides TEMPOL and TEMPO induce divergent signal transduction pathways in MDA-MB 231 breast cancer cells. Cancer. 103, 1302-1313 (1998). Demonstrates that high concentrations of TEMPO can induce a toxic effect. This result is helpful when selecting concentrations of TEMPO.
17. Zhao QL, Fujiwara Y, Kondo T. Mechanism of cell death induction by nitroxide and hyperthermia. Free Radic. Biol. Med. 40, 1131-1143 (2006).
18. Simonsen U, Christensen FH, Buus NH. The effect of TEMPOL on endothelium dependent vasodilatation and blood pressure. Pharmacol. Ther. 122, 109-124 (2009).
19. Komarov AM, Joseph J, Lai CS. In vivo pharmacokinetics of nitroxides in mice. Biochem. Biophys. Res. Commun. 201, 1035-1042 (1994). (Pubitemid 24206976)
20. Krishna MC, DeGraff W, Hankovszky OH et al. Studies of structure-activity relationship of nitroxide free radicals and their precursors as modifiers against oxidative damage. J. Med. Chem. 41, 3477-3492 (1998). (Pubitemid 28406556)
21. Yoshitomi T, Suzuki R, Mamiya T et al. pH sensitive radical-containing- nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances. Bioconjug. Chem. 20, 1792-1798 (2009). Contains details of the nanoparticle that we successfully synthesized. Describes the synthesis process and some of its properties.
22. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv. Drug Deliv. Rev. 47, 113-131 (2001). (Pubitemid 32209236)
23. Mancuso C, Bates TE, Butterfield DA et al. Natural antioxidants in Alzheimer's disease. Expert Opin. Investig. Drugs 16, 1921-1931 (2007). (Pubitemid 351403724)
24. Xiaowei L, Chenbo J, Huae X et al. Resveratrol-loaded polymeric micelles protect cells from Ab-induced oxidative stress. Int. J. Pharm. 375, 89-96 (2009).
25. Picone P, Bondi ML, Montana G et al. Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: Improved delivery by solid lipid nanoparticles. Free Radic. Res. 43, 1133-1145 (2009).
26. Adam S, Brian G, Paula CB et al. Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3- gallate (EGCG) for the treatment of Alzheimer's disease. Int. J. Pharm. 389, 207-212 (2010).
27. Yoshitomi T, Miyamoto D, Nagasaki Y. Design of core-shell-type nanoparticles carrying stable radicals in the core. Biomacromolecules 10, 596-601 (2009). Contains details of the nanoparticle that we successfully synthesized. Describes the synthesis process and some of its properties.
28. Isoda H, Koyama A, Oka S et al. Protective effect of the chinese medicinal desert plant cistanche salsa on human-derived neurotypic SH-SY5Y cells against alzheimer's disease amyloid-b-induced toxicity. J. Arid Land Studies 12, 77-82 (2002).
29. Falasca GF, Ramachandrula A, Kelley KA et al. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum. 36, 105-116 (1993). (Pubitemid 23048686)
30. Thamilselvan S, Byer KJ, Hackett RL et al. Free radical scavengers, catalase and superoxide dismutase provide protection from oxalate-associated injury to LLC-PK1 and MDCK cells. J. Urol. 164, 224-229 (2000). (Pubitemid 30434305)
31. Halliwell B, Grootveld M, Gutteridge JM. Methods for the measurement of hydroxyl radicals in biomedical systems: Deoxyribose degradation and aromatic hydroxylation. Methods Biochem. Anal. 33, 59-90 (1988).
32. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86, 271-278 (1978). (Pubitemid 9050395)
33. Ngamwongsatit P, Banada PP, Panbangred W et al. WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line. J. Microbiol. Methods 73, 211-215 (2008).
34. Yan-Ping L, Anne FB, Chi-Ming L et al. β-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res. 738, 196-204 (1996).
35. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695 (1993). (Pubitemid 23350687)
36. Behl C, Davis JB, Lesley R et al. Hydrogen peroxide mediates amyloid-β protein toxicity. Cell 77, 817-827 (1994). (Pubitemid 24187680)
37. Perl PD. Neuropathology of Alzheimer's disease and related disorders. Neurol. Clin. 18, 847-864 (2000).
38. Guan ZZ, Yu WF, Nordberg A. Dual effects of nicotine on oxidative stress and neuroprotection in PC12 cells. Neurochem. Int. 43, 243-249 (2003). (Pubitemid 36419525)
39. Miranda S, Opazo C, Larrondo LF et al. The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease. Prog. Neurobiol. 62, 633-648 (2000). (Pubitemid 30407138)
40. Rutten BP, Steinbusch HW, Korr H et al. Antioxidants and Alzheimer's disease: From bench to bedside (and back again). Curr. Opin. Clin. Nutr. Metab. Care 5, 645-651 (2002). (Pubitemid 40684630)
41. Kim DS, Kim JY, Han YS. Alzheimer's disease drug discovery from herbs: Neuroprotectivity from β-amyloid (1-42) insult. J. Altern. Complement. Med. 13, 333-340 (2007). (Pubitemid 46676776)
42. Raghavendra V, Kulkarni SK. Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radic. Biol. Med. 30, 595-602 (2001). (Pubitemid 32280785)
43. Boothby LA, Doering PL. Vitamin C and vitamin E for Alzheimer's disease. Ann. Pharmacother. 39, 2073-2780 (2005).
44. Behl C, Davis J, Cole GM et al. Vitamin E protects nerve cells from amyloid-β protein toxicity. Biochem. Biophys. Res. Commun. 186, 944-950 (1992).
45. Pappolla MA, Sos M, Omar RA et al. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17, 1683-1690 (1997). (Pubitemid 27089813)
46. Samuni A, Mitchell JB, DeGraff W et al. Nitroxide SOD-mimics: Modes of action. Free Radic. Res. Commun. 12-13, 187-194 (1991).
47. Chateauneuf J, Lusztyk J, Ingold KU. Absolute rate constants for the reactions of some carbon-centered radicals with 2,2,6,6-tetramethylpiperidine-N- oxyl. J. Org. Chem. 53, 1629-1632 (1988).
48. Kocherginsky N, Swartz HM, Seutjure M. Reactions in biology and chemistry. In:Nitroxide Spin Labels Reactions in Biology and Chemistry Kocherginsky N, Swartz HM (Eds.). CRC Press, Boca Raton, FL, USA 15-26 (1995).
49. Modi G, Pillay V, Choonara YE et al. Nanotechnological applications for the treatment of neurodegenerative disorders. Prog. Neurobiol. 88, 272-285 (2009).
50. Popovic N, Brundin P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int. J. Pharm. 314, 120-126 (2006).
51. Marushima A, Suzuki K, Nagasaki Y et al. Newly Synthesized Radical-Containing Nanoparticles (RNP) Enhance Neuroprotection After Cerebral Ischemia-Reperfusion Injury. Neurosurgery (2011) (Epub ahead of print). Study used the same nanoparticle as presented here in a cerebral ischemia-reperfusion model that focuses on a free-radical mechanism.
52. Castagna R, Davis PA, Vasu VT et al. Nitroxide radical TEMPO reduces ozone-induced chemokine IL-8 production in lung epithelial cells. Toxicol. In Vitro 23, 365-370 (2009).
53. Hahn SM, Mitchell JB, Shacter E. TEMPOL inhibits neutrophil and hydrogen peroxide-mediated DNA damage. Free Radic. Biol. Med. 23, 879-884 (1997). (Pubitemid 27402613)
54. de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro oxidant agent: Mechanisms and clinical implications. Biochem. Soc. Trans. 35, 1156-1160 (2007). (Pubitemid 350206449)
55. Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int. J. Pharm. 233, 51-59 (2002). (Pubitemid 34230418)
56. Oishi M, Hayashi H, Iijima M et al. Endosomal release and intracellular delivery of anticancer drugs using pH-sensitive PEGylated nanogels. J. Mater. Chem. 17, 3720-3725 (2007). (Pubitemid 47330703)
57. De Zwart LL, Meerman JH, Commandeur JN et al. Biomarkers of free radical damage applications in experimental animals and in humans. Free Radic. Biol. Med. 26, 202-226 (1999). (Pubitemid 29001507)